# Contingent Incentives Plus Bupropion for Smoking in People With Schizophrenia

> **NCT00136760** · PHASE2 · COMPLETED · sponsor: **Brown University** · enrollment: 57 (actual)

## Conditions studied

- Schizophrenia and Disorders With Psychotic Features
- Tobacco Use Disorder

## Interventions

- **DRUG:** Bupropion
- **DRUG:** Contingent reinforcement plus placebo
- **DRUG:** non-contingent reinforcement plus bupropion
- **DRUG:** Non-contingent reinforcement plus placebo

## Key facts

- **NCT ID:** NCT00136760
- **Lead sponsor:** Brown University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-09
- **Primary completion:** 2009-03
- **Final completion:** 2009-03
- **Target enrollment:** 57 (ACTUAL)
- **Last updated:** 2015-10-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00136760

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00136760, "Contingent Incentives Plus Bupropion for Smoking in People With Schizophrenia". Retrieved via AI Analytics 2026-09-04 from https://api.ai-analytics.org/clinical/NCT00136760. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*